Clinical Trial: Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Brief Summary: Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma
Detailed Summary:
Sponsor: Stanford University
Current Primary Outcome: Response: Globe salvage rate (Eyes saved/Eyes treated). This will be determined by clinical ocular examination. [ Time Frame: Follow-up will be performed for one year from treatment date. ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Stanford University
Dates:
Date Received: March 4, 2010
Date Started: September 2010
Date Completion: March 2012
Last Updated: May 10, 2012
Last Verified: May 2012